RGNX Operating Cash Flow (Statement)
Regenxbio Inc · Operating Cash Flow (Statement)
RGNX Operating Cash Flow (Statement)
Latest reported-$246.67Mperiod ending
RGNX TTM Cash from Operations (-$2.40M → -$246.67M)
TTM operating cash flow (statement)
High-resolution chart · PNG
RGNX operating cash flow (statement) history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -246,674,000 | |
| -233,778,000 | |
| -123,963,000 | |
| -103,297,000 | |
| -87,886,000 | |
| -84,041,000 | |
| -173,125,000 | |
| -182,261,000 | |
| -191,119,000 | |
| -192,944,000 | |
| -218,407,000 | |
| -217,019,000 | |
| -218,068,000 | |
| -232,495,000 | |
| -207,488,000 | |
| 158,121,000 | |
| 166,074,000 | |
| 197,951,000 | |
| 209,815,000 | |
| -76,954,000 | |
| -70,911,000 | |
| -62,535,000 | |
| -54,061,000 | |
| -119,035,000 | |
| -111,728,000 | |
| -113,981,000 | |
| -107,705,000 | |
| -86,339,000 | |
| -76,743,000 | |
| 17,217,000 | |
| 104,648,000 | |
| 94,962,000 | |
| 97,383,000 | |
| 17,623,000 | |
| -57,992,000 | |
| -64,589,000 | |
| -59,271,000 | |
| -58,152,000 | |
| -48,558,000 | |
| -32,578,000 | |
| -29,155,000 | |
| -28,727,000 | |
| -22,515,000 | |
| -17,934,000 | |
| -13,093,000 | |
| -5,287,000 | |
| -2,399,000 |